GrowthCurve buys control of TailorMed, XTEND cuts 10% of staff, 42AI emerges with $62.5 million
US private equity firm GrowthCurve buys a majority of TailorMed at about $250 million, drone maker XTEND lays off about 10% two months after listing, and 42AI comes out of stealth with $62.5 million.
GrowthCurve Capital buys a majority stake in TailorMed at about $250 million - TailorMed has raised about $60 million and keeps its Tel Aviv development center.
Sources: Globes, CTech, ice
XTEND lays off about 10% of staff two months after its NYSE debut - XTEND's market value has fallen from $1.5 billion at listing to about $350 million.
Sources: CTech
42AI comes out of stealth with $62.5…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.